Search all trials

Find therapies in clinical trials near you – page 28

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 962
countries: 28
conditions: 2 101

3 962 trials recruiting28 European countries2 101 conditions coveredUpdated today

Quick filters

B-cell small lymphocytic lymphoma

Not recruiting

Registered drugNo placebo

Study Comparing Zanubrutinib with Bendamustine and Rituximab for Patients with Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Registered drugNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Rituximab

Contact Research Centre

Chronic lymphocytic leukaemia

Not recruiting

Registered drugNo placebo

Study of Pirtobrutinib, Venetoclax and Rituximab combination compared to Venetoclax and Rituximab in previously treated Chronic Lymphocytic Leukemia patients

Registered drugNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Pirtobrutinib

Contact Research Centre

Systemic candida

Not recruiting

Registered drug

Study Comparing Ibrexafungerp and Fluconazole for Treating Candidemia or Invasive Candidiasis in Patients

Registered drug

Italy

Participants:18–64 years · 65+ years
Substances:Anidulafungin

Contact Research Centre

Colitis ulcerative

Not recruiting

Investigational

Study on the Effectiveness and Safety of Risankizumab for Patients with Moderate to Severe Ulcerative Colitis

Investigational

Italy

Participants:0–17 years · 18–64 years · 65+ years
Substances:Risankizumab

Contact Research Centre

Fungal infection

Not recruiting

Registered drugNo placebo

Study on the Effectiveness and Safety of Olorofim vs. Liposomal Amphotericin B for Patients with Invasive Aspergillosis

Registered drugNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Olorofim

Contact Research Centre

Relapsing multiple sclerosis

Not recruiting

Registered drug

Study on the Effectiveness and Safety of Remibrutinib Compared to Teriflunomide for Patients with Relapsing Multiple Sclerosis

Registered drug

Italy

Participants:18–64 years
Substances:Charcoal, Activated

Contact Research Centre

Diffuse large B-cell lymphoma refractory

Not recruiting

Registered drugNo placebo

Study on the Safety and Effectiveness of Polatuzumab Vedotin with Rituximab, Gemcitabine, and Oxaliplatin for Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma

Registered drugNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Oxaliplatin

Contact Research Centre

Acute lymphocytic leukaemia

Not recruiting

Registered drugNo placebo

Study on Improving Treatment for Children and Adolescents with Acute Lymphoblastic Leukemia Using Bortezomib, Blinatumomab, and a Drug Combination

Registered drugNo placebo

Italy

Participants:0–17 years
Substances:Blinatumomab

Contact Research Centre

Acute myeloid leukaemia (in remission)

Not recruiting

Registered drugNo placebo

Study on the Effectiveness of Decitabine and Venetoclax for Patients with Acute Myeloid Leukemia Unfit for Intensive Chemotherapy

Registered drugNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Decitabine

Contact Research Centre

Chronic myeloid leukaemia

Not recruiting

Registered drugNo placebo

Comparison of Nilotinib versus Imatinib treatment in newly diagnosed chronic myeloid leukemia patients to achieve treatment-free remission

Registered drugNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Imatinib

Contact Research Centre

HER2 positive breast cancer

Not recruiting

Registered drugNo placebo

Study Comparing Trastuzumab Deruxtecan and Trastuzumab Emtansine for Patients with High-Risk HER2-Positive Breast Cancer with Residual Disease After Initial Treatment

Registered drugNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Trastuzumab Deruxtecan

Contact Research Centre

Primary biliary cholangitis

Not recruiting

InvestigationalNo placebo

Study on the Long-Term Safety of Seladelpar for Patients with Primary Biliary Cholangitis

InvestigationalNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Seladelpar

Contact Research Centre

Find therapies in clinical trials near you – page 28

381 trials match your criteria

B-cell small lymphocytic lymphoma

Study Comparing Zanubrutinib with Bendamustine and Rituximab for Patients with Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Chronic lymphocytic leukaemia

Study of Pirtobrutinib, Venetoclax and Rituximab combination compared to Venetoclax and Rituximab in previously treated Chronic Lymphocytic Leukemia patients

Systemic candida

Study Comparing Ibrexafungerp and Fluconazole for Treating Candidemia or Invasive Candidiasis in Patients

Colitis ulcerative

Study on the Effectiveness and Safety of Risankizumab for Patients with Moderate to Severe Ulcerative Colitis

Fungal infection

Study on the Effectiveness and Safety of Olorofim vs. Liposomal Amphotericin B for Patients with Invasive Aspergillosis

Relapsing multiple sclerosis

Study on the Effectiveness and Safety of Remibrutinib Compared to Teriflunomide for Patients with Relapsing Multiple Sclerosis

Diffuse large B-cell lymphoma refractory

Study on the Safety and Effectiveness of Polatuzumab Vedotin with Rituximab, Gemcitabine, and Oxaliplatin for Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma

Acute lymphocytic leukaemia

Study on Improving Treatment for Children and Adolescents with Acute Lymphoblastic Leukemia Using Bortezomib, Blinatumomab, and a Drug Combination

Acute myeloid leukaemia (in remission)

Study on the Effectiveness of Decitabine and Venetoclax for Patients with Acute Myeloid Leukemia Unfit for Intensive Chemotherapy

Chronic myeloid leukaemia

Comparison of Nilotinib versus Imatinib treatment in newly diagnosed chronic myeloid leukemia patients to achieve treatment-free remission

HER2 positive breast cancer

Study Comparing Trastuzumab Deruxtecan and Trastuzumab Emtansine for Patients with High-Risk HER2-Positive Breast Cancer with Residual Disease After Initial Treatment

Primary biliary cholangitis

Study on the Long-Term Safety of Seladelpar for Patients with Primary Biliary Cholangitis

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.